ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 125 filers reported holding ABCELLERA BIOLOGICS INC in Q4 2021. The put-call ratio across all filers is 0.67 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,966 | -87.6% | 8,471 | -82.6% | 0.00% | -90.0% |
| Q2 2023 | $313,614 | +764812.2% | 48,547 | +801.2% | 0.01% | +900.0% |
| Q1 2023 | $41 | -71.3% | 5,387 | -61.9% | 0.00% | -83.3% |
| Q4 2022 | $143 | -99.9% | 14,139 | -9.9% | 0.01% | +100.0% |
| Q3 2022 | $155,000 | -7.2% | 15,690 | +0.1% | 0.00% | -25.0% |
| Q2 2022 | $167,000 | +1013.3% | 15,680 | +907.1% | 0.00% | – |
| Q1 2022 | $15,000 | +25.0% | 1,557 | +94.1% | 0.00% | – |
| Q4 2021 | $12,000 | -60.0% | 802 | -46.0% | 0.00% | -100.0% |
| Q3 2021 | $30,000 | +2900.0% | 1,484 | +2082.4% | 0.00% | – |
| Q2 2021 | $1,000 | -99.2% | 68 | -98.0% | 0.00% | -100.0% |
| Q1 2021 | $118,000 | +742.9% | 3,464 | +878.5% | 0.00% | – |
| Q4 2020 | $14,000 | – | 354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $17,358,238 | 89.37% |
| Founders Fund Growth Management, LLC | 407,017 | $1,872,278 | 5.10% |
| Prosight Management, LP | 2,446,000 | $11,251,600 | 3.57% |
| Intellectus Partners, LLC | 876,633 | $4,032,511 | 1.28% |
| Belmont Capital, LLC | 510,000 | $2,346,000 | 1.27% |
| Casdin Capital, LLC | 2,360,129 | $10,856,593 | 1.20% |
| GUARDIAN CAPITAL ADVISORS LP | 1,786,414 | $7,842,357 | 0.88% |
| Baker Brothers Advisors | 20,763,323 | $95,511,286 | 0.55% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $262,090 | 0.44% |
| Orbimed Advisors | 4,180,768 | $19,231,533 | 0.41% |